TCI Wealth Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

TCI Wealth Advisors’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-99	Closed	-$1K	–	2672
2021 Q2	$1K	Hold	99	–	–	﹤0.01%	2294
2021 Q1	$0	Hold	99	–	–	﹤0.01%	2281
2020 Q4	$0	Hold	99	–	–	﹤0.01%	1732
2020 Q3	$0	Buy	+99	New	+$414	﹤0.01%	1720
2020 Q2	–	Sell	-201	Closed	-$1K	–	1750
2020 Q1	$1K	Sell	201 -78	-28%	-$662	﹤0.01%	1413
2019 Q4	$2K	Buy	+279	New	+$2.18K	﹤0.01%	1254

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

TCI Wealth Advisors's KIN Position: Q3 2021 in Review

TCI Wealth Advisors sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 99 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in KIN in Q4 2019 and held it in 6 quarters. The position peaked at $2K in Q4 2019. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

TCI Wealth Advisors reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
TCI Wealth Advisors sold 99 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1K.
TCI Wealth Advisors first reported a position in Kindred Biosciences, Inc. in Q4 2019 and held it in 6 quarters.
TCI Wealth Advisors's Kindred Biosciences, Inc. position peaked at $2K in Q4 2019.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on TCI Wealth Advisors's 13F filing for Q3 2021, filed 29 Oct 2021.